ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research, and care delivery issues unique to countries and settings with limited health care resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author. Credentialed media can access published articles on the ASCO Publications site using their ASCO.org login information.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing May 17, 2024, 4:00 PM ET:

Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial (Original Report)
Patrick Stone, et al
Request article 

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline (Special Article)
ASCO Guideline, et al
Request article 

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights (Special Article)
ASCO Guideline, et al
Request article 

Publishing May 16, 2024, 4:00 PM ET:

Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update (Special Article)
ASCO Guideline, et al
Request article 

The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings (Original Report)
Rawan Hammad, et al
Request article 

Second Chance for Cure. Stereotactic Ablative Radiotherapy in Oligometastatic Disease (Original Report)
Kristina Tumanova, et al
Request article 

Clinicopathological Profile and Treatment Outcomes of Colorectal Cancer in Young Adults: A Multicenter Study from India (Original Report)
Amit Sehrawat, et al
Request article 

Global Incidence of Ovarian Cancer According to Histological Subtype: A Population-Based Cancer Registry Study (Original Report)
Yinzi Jin, et al
Request article 

Impact of Fee-For-Service on the Efficiency and Survival of Seguro Popular's Acute Lymphoblastic Leukemia Patients in Mexico (Original Report)
Sergio Bautista-Arredondo, et al
Request article 

Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non–Small Cell Lung Cancer (Original Report)
Monika Izano, et al
Request article 

RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer (Original Report)
Pratik Chandrani, et al
Request article 

Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial (Original Report)
Joyce Liu, et al
Request article 

Publishing May 15, 2024, 4:00 PM ET:

Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study (Original Report)
ASCO TAPUR, et al
Request article 

Palliative Care for Patients With Cancer: ASCO Guideline Update (Original Report)
ASCO Guidelines, et al
Request article 

Intimate Care Products and Incidence of Hormone-Related Cancers: A Quantitative Bias Analysis (Original Report)
Katie O'Brien, et al
Request article 

Epidemiologic Methods to Advance Our Understanding of Ovarian Cancer Risk (Editiorial)
Holly Harris, et al
Request article 

Predicting the Future by Studying the Past for Patients With Cancer Diagnosed in the Emergency Department (Editorial)
Emily Miller Ray, et al
Request article 

Palliative Care for Patients With Cancer: ASCO Guideline Clinical Insights (Original Report)
ASCO Guidelines, et al
Request article 

Value of Real-World Evidence for Treatment Selection: A Case Study in Colon Cancer (Original Report)
Lingjie Shen, et al
Request article 

Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer (Original Report)
Jonathan Tward, et al
Request article 

Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches (Original Report)
Pedro Barata, et al
Request article 

Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2–Positive Advanced Gastric Cancer (Original Report)
Eishi Baba, et al
Request article 

Published May 14, 2024, 4:00 PM ET:

Prostate-Specific Antigen Nadir Postradiotherapy in Localized Prostate Cancer: Is It Prognostic or Predictive? (Editorial)
Daniel Eidelberg Spratt, et al
Request article 

Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer (Original Report)
Lucas Moreno, et al
Request article 

DPYD Pharmacogenetics: To Opt-in or to Opt-out (Editorial)
Alan P. Venook, et al
Request article 

Publishing May 13, 2024, 4:00 PM ET:

Differences in Rural Versus Urban Patients With Prostate Cancer in Diagnosis and Treatment: An Analysis of a Population-Based Cohort (Original Report)
Xinglei Shen, et al
Request article 

Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer (Editorial)
Vivek Subbiah, et al
Request article 

Published May 10, 2024, 4:00 PM ET:

Clinical Trials—Real-World Data to Build a Future for Our Patients (Editorial)
W. Kimryn Rathmell, et al
Request article 

Recently published Journal articles are featured on the homepage of each ASCO Journal website. Credentialed media can directly access these articles using their Media HQ login information on the Journal website. You will only need to log in once to access content for all ASCO Journals:

To apply for ASCO media credentials or renew your credentials, visit ASCO’s Media Headquarters and click “Create Account” or log in with your existing account information. To request your username or reset your password, click “Need Help. After submitting the required documentation, you will receive an email notification once your media credentials are approved. Your access to Journal articles will be activated within one week of approval. As you await access, once you have received notification of approved media credentials, submit your requested articles to Journal Request to receive them by email. 

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.Publishing May 9, 2024, 4:00 PM ET: